ARTICLE | Company News
Ascentia Biomedical, University of Washington deal
August 22, 2005 7:00 AM UTC
ASCE received an option from the university to license an undisclosed family of compounds. The option includes preclinical compounds for breast cancer, sepsis and arthritis. ...